SCHEMBL2093191

SCHEMBL2093191

O=[C]OCc1c(F)c(F)c(F)c(F)c1F

nearest known ligand 0.33

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
MMP1 P03956 1/20 0.30
MMP2 P08253 1/20 0.30
MMP9 P14780 1/20 0.30
MMP12 P39900 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5536679 0.72 MMP1 (0.37) MMP1MMP2MMP9MMP12
SCHEMBL3933366 0.67 CA12 (0.34) CA12CA1CA2CA7CA9
SCHEMBL98902 0.67 MAOB (0.41)
SCHEMBL95538 0.64 IDO1 (0.52) CA12CA1CA2CA7CA9
SCHEMBL3251305 0.64 IDO1 (0.52) CA12CA1CA9MMP1MMP2
SCHEMBL7196008 0.63 CA12 (0.37) CA12CA1CA2CA7CA9
SCHEMBL778583 0.63 CA1 (0.41) CA12CA1CA2CA7CA9
SCHEMBL2093193 0.63 CA12 (0.33) CA12CA1CA2CA7CA9
SCHEMBL778189 0.63 CA12 (0.33) CA12CA1CA2CA7CA9
SCHEMBL3691321 0.63 MMP1 (0.44) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4647581-A Bicyclic pesticidal agents BAYER AKTIENGESELLSCHAFT (DE) 1987-03-03 US claimed
EP-0084600-B1 SUBSTITUTED BICYCLIC DERIVATIVES AND THEIR USE AS INSECTICIDES BAYER AG (DE) 1986-06-25 EP claimed
EP-0084600-A1 Substituted bicyclic derivatives and their use as insecticides BAYER AG (DE) 1983-08-03 EP claimed
EP-0004022-B1 PENTAFLUOROBENZYLOXYCARBONYL DERIVATIVES, METHOD FOR THEIR PREPARATION AND THEIR USE AS INSECTICIDES AND ACARICIDES BAYER AG (DE) 1981-09-16 EP claimed
JP-57098239-A None JP disclosed
EP-2570418-A2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-03-20 EP disclosed
EP-1555267-B1 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES OTSUKA PHARMA CO LTD (JP) 2013-01-16 EP disclosed
US-8163753-B2 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2012-04-24 US disclosed
EP-1678185-B1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMA CO LTD (JP) 2008-10-08 EP disclosed
US-20080119478-A1 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis OTSUKA PHAMACEUTICAL CO., LTD. (JP) 2008-05-22 US disclosed
US-7262212-B2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-28 US disclosed
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
EP-1555267-A1 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-07-20 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed
US-4647581-A Bicyclic pesticidal agents BAYER AKTIENGESELLSCHAFT (DE) 1987-03-03 US disclosed
EP-0084600-B1 SUBSTITUTED BICYCLIC DERIVATIVES AND THEIR USE AS INSECTICIDES BAYER AG (DE) 1986-06-25 EP disclosed
US-4423066-A MITICIDES, INSECTICIDES BAYER AKTIENGESELLSCHAFT (DE) 1983-12-27 US disclosed
EP-0084600-A1 Substituted bicyclic derivatives and their use as insecticides BAYER AG (DE) 1983-08-03 EP disclosed
JP-S5798239-A PENTAFLUOROBENZYLOXYCARBONYL DERIVATIVE, AND INSECTICIDE CONTAINING IT AS ACTIVE INGREDIENT NISSAN CHEM IND LTD 1982-06-18 JP disclosed
EP-0004022-A1 Pentafluorobenzyloxycarbonyl derivatives, method for their preparation and their use as insecticides and acaricides BAYER AG (DE) 1979-09-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119478-A1 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis NR2C2, NR0B2, NR4A2 CA12 3179/4885CA1 4171/4885CA2 2002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.